ASSESSMENT OF MINIMAL RESIDUAL DISEASE (MRD) BY DETECTION OF SYT-SSX FUSION TRANSCRIPT (SFT) IN PERIPHERAL BLOOD (PB) OF PATIENTS WITH SYNOVIAL SARCOMA


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles